ARMO BioSciences *
ARMO BioSciences was a clinical-stage immuno-oncology biopharmaceutical company based in Redwood City, California, developing biologic therapeutics that activate a patient's own immune system to fight cancer. Its lead candidate was pegilodecakin (AM0010), a PEGylated recombinant human interleukin-10 (IL-10) evaluated across solid tumors. Backed by GV and Kleiner Perkins, the company IPO'd on NASDAQ in 2018 and was acquired by Eli Lilly and Company that same year for approximately $1.6 billion; its former web domain now redirects to lilly.com. As a life-sciences therapeutics developer it exposes no public developer API, SDK, or documentation surface. This profile is retained in the API Evangelist network as a portfolio/acquisition record rather than an active API provider.
ARMO BioSciences * is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Resources
Every other property we hold for ARMO BioSciences * — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Other 1
Properties that don't map to a standard resource type
ARMO BioSciences * is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/armo-biosciences · machine-readable index on apis.io
This is an independent, third-party profile of ARMO BioSciences *, published by API Evangelist. We do not operate, host, resell, or support these APIs, and we are not affiliated with or endorsed by the company unless stated above. Everything here is built from publicly available information — the company's own site, developer portal, documentation, public repositories, and the specifications it publishes for public use. Nothing is obtained by breaching a system, defeating an access control, or using credentials.
The Kin Score and Agent Readiness rating are independently calculated assessments of a company's public API artifacts, scored against a published rubric. They are not certifications, endorsements, security assessments, or audits.
Corrections, re-scores, and removal are free — no partnership or purchase required, and you do not need to justify the request. A removed company is recorded as unrated, never scored zero for having asked. Acknowledgement within one business day; removal within two.
info@apievangelist.com
·
Read the full data-sourcing policy →
On a security or compliance team? Put security in the subject line and
you will get a person, not a form — we will tell you exactly which public URLs this profile was built from.